Press Room

Today’s executive order jeopardizes the ability of millions of cancer patients, survivors and those at risk for the disease from being able to access or afford meaningful health insurance. Exempting an entire set of health plans from covering essential health benefits like prescription drugs or specialty care and allowing expansion and renewability of bare-bones short-term plans will split the insurance market.

More than 11 years after a federal court first ordered them to do so, the major U.S. tobacco companies must begin publishing “corrective statement” advertisements next month telling the American people the truth about their deadly and addictive products, if the court accepts an agreement filed late Monday.

Dozens of patients from across the country, each with their own personal health care story, gathered on Capitol Hill today to urge their senators to preserve quality health care coverage for millions of Americans and reject the pending Graham-Cassidy health care legislation.

Changes to the nation’s healthcare system as proposed in the pending Graham-Cassidy health legislation could leave millions of cancer patients and survivors without access to adequate, affordable health insurance coverage, according to Dick Woodruff, senior vice president of federal advocacy for ACS CAN.

This week the Senate HELP Committee is hearing from bipartisan health care experts in its ongoing effort to strengthen the individual insurance market and ensure that meaningful, affordable health care coverage is available for millions of Americans, including cancer patients, survivors and their families.

The Congressional Budget Office (CBO) today released its assessment of what would happen to health insurance premiums should the administration stop paying cost-sharing reductions (CSRs).

The CBO projects the average monthly premiums would increase 20 percent next year and 25 percent by 2020. 

The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer. 

The U.S. Food and Drug Administration announced today a new, comprehensive approach to confront nicotine addiction in the U.S. through the agency’s authority over tobacco products. 

The U.S. Senate is reported to be considering a “skinny” health care repeal bill that according to earlier Congressional Budget Office estimates of similar repeal could cause 15 million Americans to lose their insurance coverage over the next ten years

A new report shows that while opportunities for coverage have improved, cancer patients still struggle with significant financial challenges in affording their treatment despite substantial reductions in out-of-pocket costs and patient protections under current law.